Table 1. Data of the 20 patients with multiple recurrences of HCC after liver transplantation.

Variable	TACE	TACE+Sorafenib	P
Gender
Male	10	10	-
Age(year)	43.40±7.31	46.30±5.95	0.327
AFP(ng/mL)			0.785
≤ 20	1	1
20-400	4	2
400-1000	1	1
> 1000	4	6
Tumor size(cm)	9.98±1.96	9.52±4.63	0.778
Multiple recrudescence			0.656
No	6	4
yes	4	6
Vascular tumor thrombi			1.000
No	3	4
yes	7	6
Hepatic cirrhosis			1.000
No	3	2
yes	7	8
Child-Pugh score			1.000
A	6	5
B	4	5
Bilirubin (μmol/L)			0.350
≤ 34	5	8
> 34	5	2
White protein (g/L)			0.582
≤ 35	1	3
> 35	9	7
Tumor free survival time (month)			1.000
≤ 12	6	5
> 12	4	5